Cns Pharmaceuticals Inc [NASDAQ: CNSP] traded at a high on Tuesday, posting a 12.40 gain after which it closed the day’ session at $1.36.
The results of the trading session contributed to over 91320818 shares changing hands. Over the past one week, the price volatility of Cns Pharmaceuticals Inc stands at 31.89% while the volatility over the past one month is 16.57%.
The market cap for CNSP stock reached $4.00 million, with 2.94 million shares outstanding and 2.92 million shares in the current float. Compared to the average trading volume of 501.11K shares, CNSP reached a trading volume of 91320818 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Cns Pharmaceuticals Inc [CNSP]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CNSP shares is $25.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CNSP stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Cns Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on December 28, 2020. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on August 24, 2020, representing the official price target for Cns Pharmaceuticals Inc stock.
The Average True Range (ATR) for Cns Pharmaceuticals Inc is set at 0.27 The Price to Book ratio for the last quarter was 0.31, with the Price to Cash per share for the same quarter was set at 2.20.
How has CNSP stock performed recently?
Cns Pharmaceuticals Inc [CNSP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 23.64. With this latest performance, CNSP shares gained by 1.49% in over the last four-week period, additionally sinking by -75.95% over the last 6 months – not to mention a drop of -99.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CNSP stock in for the last two-week period is set at 52.98, with the RSI for the last a single of trading hit 69.30, and the three-weeks RSI is set at 45.35 for Cns Pharmaceuticals Inc [CNSP]. The present Moving Average for the last 50 days of trading for this stock 1.6923, while it was recorded at 1.1910 for the last single week of trading, and 5.6811 for the last 200 days.
Cns Pharmaceuticals Inc [CNSP]: Deeper insight into the fundamentals
Cns Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.42 and a Current Ratio set at 3.42.
Earnings analysis for Cns Pharmaceuticals Inc [CNSP]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CNSP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Cns Pharmaceuticals Inc go to 65.40%.
Insider trade positions for Cns Pharmaceuticals Inc [CNSP]
There are presently around $2.07%, or 2.08%% of CNSP stock, in the hands of institutional investors.
